Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Multidose, Study to Assess the Tolerability and Pharmacokinetics of Oxylanthanum Carbonate at Clinically Effective Doses in Patients With Chronic Kidney Disease on Dialysis

NCT06218290 is registered in ClinicalTrials.gov with Unicycive Therapeutics, Inc as lead sponsor.

NCT NCT06218290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06218290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Multidose, Study to Assess the Tolerability and Pharmacokinetics of Oxylanthanum Carbonate at Clinically Effective Doses in Patients With Chronic Kidney Disease on Dialysis
Lead sponsor
Unicycive Therapeutics, Inc
Phase
Phase 2
Overall status
Completed
Start date
December 15, 2023
Completion date
May 29, 2024
Enrollment
106 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease requiring chronic dialysis